Medication errors in intensive care units occur at alarming rates, with unintended adverse drug events affecting 5% of hospitalized patients annually and contributing to doubled mortality risk. A multi-institutional research team led by the University of Georgia has developed PharmacyGPT, […]
University of Georgia Tests AI Framework for Intensive Care Medication Decision Support Read More »
Detecting Alzheimer’s disease early remains challenging, as current methods require invasive procedures or expensive centralized equipment unsuitable for widespread screening. Researchers at the University of Naples Federico II have developed a cost-effective electrochemical sensor that detects beta-amyloid peptides directly in
As mental health treatment developers seek funding to advance clinical programs through late-stage trials, psychedelic medicine companies face particular scrutiny over their path to commercialization. Cybin Inc., a Toronto-based neuropsychiatry company, recently closed a $175 million registered direct offering to
Cybin Secures $175M to Advance Psychedelic Depression Trials Read More »
Patent disputes over wearable technology, such as electronic eyewear, continue to shape the competitive landscape. IngenioSpec, a company based in Waco, Texas and San Jose, California, announced on October 31, 2025 that it has reached a settlement with HTC to
IngenioSpec and HTC Settle Patent Dispute Over Electronic Eyewear Read More »
CareScout, a Genworth Financial subsidiary, has completed its acquisition of Seniorly, Inc., a technology platform and advisor network that connects families with senior living communities and resources. The deal, valued at approximately $15 million, was funded from Genworth’s existing holding
CareScout Acquires Senior Living Platform Seniorly for $15M Read More »
Sepsis causes 48.9 million cases and 11 million deaths worldwide each year, accounting for approximately one in five of all global deaths. ABIONYX Pharma recently announced that a study published in Scientific Reports provides genetic evidence linking apolipoprotein A-I (ApoA-I)
Genetic Study Links Apolipoprotein A-I to Sepsis Outcomes Read More »
Amalgam Rx has published two peer-reviewed studies reporting engagement metrics for its Medical-Grade AI™ framework, which includes clinical guardrails and personality-driven design for large language models in healthcare settings. Key Points The reported engagement metrics suggest that combining clinical oversight
Amalgam Rx Reports Higher Engagement Metrics with AI Guardrail System Read More »
Median Technologies has secured financing to support its AI-powered lung cancer screening software through anticipated regulatory approvals and commercial launch. The company announced today that it has received €19 million from the European Investment Bank, representing the first tranche of
Median Technologies Receives €19M From EIB to Support AI Cancer Screening Read More »
Healthcare providers continue experimenting with AI for patient communications as the technology’s real-world effectiveness remains under evaluation. In the latest such effort, University Hospitals, an Ohio-based academic health system, announced a collaboration with Hippocratic AI to deploy conversational AI agents
Access to healthcare data remains a barrier to AI-driven clinical research, with companies seeking ways to aggregate and analyze patient information while maintaining regulatory compliance. OneMedNet Corporation has selected Palantir Technologies to provide AI infrastructure for its real-world data analytics
OneMedNet Partners with Palantir for Healthcare Data Analytics Platform Read More »
